Control of Follicle‐Stimulating Hormone and Luteinizing Hormone Release by Hypothalamic Peptidesa
- 1 May 1993
- journal article
- review article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 687 (1) , 55-59
- https://doi.org/10.1111/j.1749-6632.1993.tb43853.x
Abstract
Lesion, stimulation, and pharmacological studies point to separate hypothalamic control of pulsatile FSH and LH secretion. LH release is controlled by a region extending from the preoptic area to the anterior and mid-median eminence, whereas FSH release is controlled by a region extending from the dorsal anterior hypothalamic area to the caudal median eminence. We have separated an FSH-releasing factor from LHRH by gel-filtration on Sephadex G-25, confirming results obtained over 25 years ago; and we are attempting its isolation in collaboration with Vale and River. In the meantime, reasoning that FSH-releasing factor might be related to LHRH, we tested many analogs of LHRH and found one that has selective FSH-releasing activity over a 50-fold dose range; however, it is relatively weak. This led us to the possibility that the GAP might be FSH-RF. Indeed, GAP1-13 has FSH but no LH-releasing activity over a 100-fold dose range; however, it is less potent than we would expect of the natural product. Substituting D-Trp-9 into the molecule to inhibit enzymatic degradation yielded a more potent and completely selective FSH-releasing peptide,24 which could be clinically useful. Alpha-inhibin-92 of Li et al. has been shown to have a highly selective dose-related suppressive action on FSH release in castrate male rats.25 Smaller fragments (35-65 and 66-92) of this molecule also possess the activity, albeit at higher doses. That this molecule may be physiologically significant is indicated by elevations in plasma FSH in immature rats obtained following intravenous injection of antisera raised against the peptide. Because of its much smaller size than that of 32-kDa alpha, beta inhibins and the lack of carbohydrate in the molecule, this can be relatively easily synthesized and might have clinical utility as an FSH release-inhibiting peptide.Keywords
This publication has 23 references indexed in Scilit:
- Altered gonadotropin and prolactin release induced by median eminence (ME) lesions and pharmacological manipulation of prolactin release: Further evidence for separate hypothalamic control of FSH and LH releaseBrain Research Bulletin, 1989
- Destruction of the Dorsal Anterior Hypothalamic Region Suppresses Pulsatile Release of Follicle Stimulating Hormone but Not Luteinizing HormoneNeuroendocrinology, 1989
- Purification and characterization of an FSH releasing protein from porcine ovarian follicular fluidNature, 1986
- Complementary DNA sequences of ovarian follicular fluid inhibin show precursor structure and homology with transforming growth factor-βNature, 1985
- Ethanol and the pulsatile release of luteinizing hormone, follicle stimulating hormone and prolactin in ovariectomized ratsAlcohol, 1985
- Effect of Destruction of the Dorsal Anterior Hypothalamus on Follicle-Stimulating Hormone Secretion in the Rat*Endocrinology, 1984
- Evidence for an FSH-releasing factor in the posterior portion of the rat median eminenceLife Sciences, 1983
- Physiology and Pharmacology of LHRH and SomatostatinAnnual Review of Pharmacology and Toxicology, 1982
- The Effects of Hypothalamic Lesions on the Release of Gonadotropins and Prolactin in Response to Estrogen and Progesterone Treatment in Female RatsEndocrinology, 1972
- Effects of Hypothalamic and Preoptic Electrochemical Stimulation on Gonadotropin and Prolactin Release in Proestrous RatsEndocrinology, 1971